Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

PHASE2CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Complicated Intra-abdominal Infections
Interventions
DRUG

ceftazidime/NXL104 + metronidazole

IV TID

DRUG

meropenem

IV TID

Trial Locations (45)

90033

University of Southern California, Los Angeles

Unknown

Cedars-Sinai Medical Center Dept of Surgery, Los Angeles

Michael S. Somero Research Division, Palm Springs

Henry Ford Health System, Detroit

Mercury Street Medical Group, Butte

South Jersey Infectious Disease, Somers Point

Summa Health Systems, Akron

Remington-Daviss Inc, Columbus

ID Clinical Research Ltd, Toledo

UMHAT Sveti Georgi 3rd Clinical of Surgery, Plovdiv

MHAT Rousse, 2nd Clinical of Surgery, Rousse

CCB Ministry of Interior Clinical of Surgery, Sofia

Multiprofile Hospital for Active Trt Emergency Med, Sofia

UMHAT Queen Joanna-ISUL, Clinical of Surgery, Sofia

Hospital Saint Joseph Marseille, Marseille

Hospital L'Archet II, Nice

CHU Nimes, Nîmes

Medisurge Hospital Ahmedabad, Ahmedabad

Medisys Clinisearch India Pvt Ltd, Bangalore

MS Ramaiah Memorial Hospital Bangalore, Bangalore

Victoria Hospital Bangalore, Bangalore

Suyash Hospital Indore, Indore

SR Kalla General and Gastro Hospital, Jaipur

Amrita Institute of Medical Sciences, Cochin, Kochi

Lucknow Cancer Institute Lucknow, Lucknow

Al-Zahraa university Hospital, Beirut

Makassed General Hospital, Beirut

Rafik Heriri University Hospital, Beirut

Hammound Hospital University Medical Center, Saida

Labib Medical Center, Saida

Slaski Uniwersytet Medyczny, Katowice

Pomorskie Centrum Traumatologii, Nowe Ogrody

Katedra i Klinika Chirurgii Ogolnej, Warsaw

Samodzielny Publiczny, Warsaw

Akademicki Szpital Kliniczn, Wroclaw

Coltea Clinical Hospital, Bucharest

Floreasca Clinical Emergency Hospital, Bucharest

Fundeni Clinical Institute, Bucharest

University Emergency Hospital Bucharest, Bucharest

City Clinical Hospital # 13, Moscow

City Clinical Hospital # 1, Moscow

FGU National Medical Surgery, Moscow

Moscow City Clinical Hospital # 31, Moscow

SMO of Clinical Trials, Smolensk

North-Ossetian Medical Academy, Vladikavkas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY